SCHEMBL17130322

SCHEMBL17130322

CC(C)(C)[Si](C)(C)O[C@H]1C[C@H](c2cnc3c(N)ncnn23)O[C@]1(C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17106841 0.90 — —
SCHEMBL17106774 0.87 — —
SCHEMBL17106691 0.86 — —
SCHEMBL19412686 0.81 SLC28A1 (0.32) —
SCHEMBL17106733 0.78 STING1 (0.31) —
SCHEMBL17131357 0.75 STING1 (0.30) —
SCHEMBL17106816 0.75 POLRMT (0.34) —
SCHEMBL17106802 0.75 POLRMT (0.34) —
SCHEMBL19412766 0.74 SLC28A1 (0.32) —
SCHEMBL17106826 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015148746-A1 4'-SUBSTITUTED NUCLEOSIDE-DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-10-01 — — WO disclosed
Send feedback